• Market

India Ratings and Research (Fitch Group) – In-licensing Route to Offer Modest Benefits to Domestic Prescription Businesses

New Delhi, November 22, 2018: India Ratings and Research (Ind-Ra) believes in-licensing pursuits by Indian pharmaceutical formulators for the domestic…